These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25532482)

  • 1. Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis.
    Li C; Bo L; Liu Q; Jin F
    Int J Infect Dis; 2015 Apr; 33():90-6. PubMed ID: 25532482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.
    Liu F; Wang HM; Wang T; Zhang YM; Zhu X
    BMC Infect Dis; 2016 Sep; 16():488. PubMed ID: 27633969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulinastatin- and thymosin α1-based immunomodulatory strategy for sepsis: A meta-analysis.
    Han D; Shang W; Wang G; Sun L; Zhang Y; Wen H; Xu L
    Int Immunopharmacol; 2015 Dec; 29(2):377-382. PubMed ID: 26522590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulinastatin and/or thymosin α1 for severe sepsis: A systematic review and meta-analysis.
    Feng Z; Shi Q; Fan Y; Wang Q; Yin W
    J Trauma Acute Care Surg; 2016 Feb; 80(2):335-40. PubMed ID: 26517783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.
    Wu J; Zhou L; Liu J; Ma G; Kou Q; He Z; Chen J; Ou-Yang B; Chen M; Li Y; Wu X; Gu B; Chen L; Zou Z; Qiang X; Chen Y; Lin A; Zhang G; Guan X
    Crit Care; 2013 Jan; 17(1):R8. PubMed ID: 23327199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients.
    Liu D; Yu Z; Yin J; Chen Y; Zhang H; Xin F; Fu H; Wan B
    J Crit Care; 2017 Jun; 39():259-266. PubMed ID: 28069319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy and Immunomodulatory Effects of Ulinastatin and Thymosin α1 for Sepsis: A Systematic Review and Meta-Analysis.
    Wang FY; Fang B; Qiang XH; Yu TO; Zhong JR; Cao J; Zhou LX
    Biomed Res Int; 2016; 2016():9508493. PubMed ID: 27340674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of efficacy of thymosin alpha1 in the treatment of sepsis: a systematic review].
    Yu Y; Tian JH; Yang KH; Zhang P
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):21-4. PubMed ID: 19141185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond.
    Danielli R; Fonsatti E; Calabrò L; Di Giacomo AM; Maio M
    Ann N Y Acad Sci; 2012 Oct; 1270():8-12. PubMed ID: 23050811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with thymosin alpha1 and dexamethasone helps mice survive sepsis.
    Xiang XS; Li N; Zhao YZ; Li QR; Li JS
    Inflammation; 2014 Apr; 37(2):402-16. PubMed ID: 24122349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymosin alpha1- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria.
    Zhang Y; Chen H; Li YM; Zheng SS; Chen YG; Li LJ; Zhou L; Xie HY; Praseedom RK
    J Infect Dis; 2008 Sep; 198(5):723-30. PubMed ID: 18613793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of patients with severe sepsis using ulinastatin and thymosin alpha1: a prospective, randomized, controlled pilot study.
    Chen H; He MY; Li YM
    Chin Med J (Engl); 2009 Apr; 122(8):883-8. PubMed ID: 19493408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
    Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
    Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1.
    Li Yumin ; Chen Hao ; Li Xun ; Zhou Wence ; He Minyan ; Chiriva-Internati M; Wachtel MS; Frezza EE
    J Intensive Care Med; 2009; 24(1):47-53. PubMed ID: 19033321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients.
    Liu D; Yu Z; Yin J; Chen Y; Zhang H; Fan X; Fu H; Wan B
    J Crit Care; 2017 Jun; 39():285-287. PubMed ID: 28283220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin alpha 1 treatment for patients with sepsis.
    Pei F; Guan X; Wu J
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):71-76. PubMed ID: 30063866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
    Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
    Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Historical review of thymosin α 1 in infectious diseases.
    Camerini R; Garaci E
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S117-27. PubMed ID: 26098768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Historical review on thymosin α1 in oncology: preclinical and clinical experiences.
    Garaci E; Pica F; Matteucci C; Gaziano R; D'Agostini C; Miele MT; Camerini R; Palamara AT; Favalli C; Mastino A; Serafino A; Sinibaldi Vallebona P
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S31-9. PubMed ID: 26096345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a C-end rule modification on antitumor activity of thymosin α1.
    Wang F; Xu C; Peng R; Li B; Shen X; Zheng H; Lao X
    Biochimie; 2018 Nov; 154():99-106. PubMed ID: 30096371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.